Weizmann in the Media | Donor Spotlights
A Visionary Gift
The Weizmann Institute of Science is moving forward on the development of novel therapies in the name of Dr. Barry Sherman

As the founder of Apotex, Canada's largest generic pharmaceutical manufacturer, Barry Sherman was a brilliant scientist with a dream and a purpose. He held a PhD in astrophysics from the Massachusetts Institute of Technology, where he obtained a gold medal for his academic achievements. Barry founded Apotex with a mission of improving access to medicines for millions of patients worldwide.

Barry’s children recently made a major gift in his honour to support leading Weizmann Institute scientists in their quest to develop optimal treatment regimens of universal importance to human health.

The Dr. Barry Sherman Institute for Medicinal Chemistry will facilitate and advance innovative ideas, empowering Weizmann scientists and leading to new options for future therapeutic treatments. Such an initiative is expected to have significant benefits for a range of diseases and disorders, including cancer, autoimmune, neurodegenerative, and infectious diseases.

Among the investigations that are expected to be undertaken at the Sherman Institute are efforts to develop new antibiotics so as to overcome the growing challenge of antibiotic resistance; harnessing plant metabolites for potential drugs, including an unprecedented method of bioengineering plants to generate L-DOPA, the leading drug for the treatment of Parkinson’s disease; and advancing the development of a promising, effective, and inexpensive anti-malaria drug compound.

Together with his wife, Honey, Barry was committed to making an impact through significant charitable initiatives. They began supporting the Weizmann Institute of Science in the early 1980s because they believed in the importance of basic scientific research for the benefit of humanity.

Barry was an outstanding scientist, and the field of medicinal chemistry was close to his heart. With this visionary gift, his legacy will live on in support of the Weizmann lnstitute’s cutting-edge research. We are extremely grateful.

Related Stories
Press Release, Weizmann in the Media
On May 16 Weizmann Canada’s Montreal Chapter hosted a gala event dedicated to celebrating the philanthropic partners who support the work of researchers at the Weizmann Institute of Science. The event, called “LIMITLESS”, hosted more than 300 philanthropic leaders and members of the Montreal community.
To the Moon
Weizmann in the Media, Science Stories
Israel’s first unmanned interplanetary spacecraft will launch in the beginning of 2019 aboard a SpaceX Falcon 9 rocket from the Kennedy Space Station in Cape Canaveral, Florida. If it lands on the Moon two months later, as hoped, Israel will join an exclusive club of countries—U.S., Russia, and China—that have sent spacecraft to the surface of Earth’s nearest planetary neighbor. The spacecraft was recently named Beresheet, the Hebrew word for ‘beginning’ and Genesis, the first book of the Old Testament.
Yaron Lipman
Weizmann in the Media, Science Stories
Yaron Lipman is a professor in the computer science and applied mathematics department at the Weizmann Institute in Rehovot, Israel. Lipman heads a team doing cutting-edge research into the development of new technologies that can allow computers to capture images, analyze and manipulate them, and construct fragments into a coherent image. Lipman spoke to Weizmann supporters in Toronto, Montreal and Calgary recently.